Supplemental Table
Table S1. Chronic lithium administration is effective against FX audiogenic seizures.
|
Strain |
Li chow duration |
AGS |
AGS observed (%) |
% nl |
av. Li level mmol/L |
t-test Li level AGS+v.- |
weight (g.) av. |
% nl chow |
t-test weight. AGS+v.- |
|
FVB-FX |
9^d. |
10/17- 7/17+ |
41 |
~45 |
20 2.2+ |
p=0.55 |
13.3- 13.5+ |
62 65 |
p=0.93 |
|
FVB-FX |
29 d. |
5/8- 3/8+ |
38 |
~41 |
28- 2.9+ |
p=0.89 |
5^2- 4.5+ |
24 22 |
p=0.36 |
|
HYB-FX |
7"d. |
9/9- 0/9+ |
0 |
1.0 (± 0.1) |
n.a. |
13.2 (± 0.4) |
n.a. | ||
|
FVBwt |
9^d. |
17/17- 0/17+ |
0 |
~33 |
1.4 (± 0.1) |
n.a. |
11.1 (± 0.3) |
55 |
n.a. |
|
HYBwt |
7"d. |
7/7- 0/7+ |
0 |
0.58 (± 0.04) |
n.a. |
16.2 (± 0.8) |
67 |
n.a. | |
|
HYBwt |
29 d. |
6/6- 0/6+ |
0 |
2.2 (± 0.1) |
n.a. |
5.4 (± 0.2) |
22 |
n.a. |
Table S1. Chronic lithium administration is effective against FX audiogenic seizures.
All lithium carbonate chow durations refer to the administration time prior to the test (d=days).
There was no normal chow wash out period. Abbreviations: “AGS” is audiogenic seizure; “nl” is
normal, and “av” is average. For numbers of mice, “-“ indicates the sub-group of treated mice
which did not have seizures; “+” indicates the sub-group of mice which did. “% nl chow AGS”
represents a comparison of the AGS levels after Li chow to those obtained with the same sex,
age, and strain of mice eating normal chow, for which our historical averages have been
approximately 92% for FVB-FX and 20% for FVB-wt (see also Figure 1). “t-test Li AGS + v. -“
More intriguing information
1. The name is absent2. Cyber-pharmacies and emerging concerns on marketing drugs Online
3. Markets for Influence
4. Epistemology and conceptual resources for the development of learning technologies
5. A multistate demographic model for firms in the province of Gelderland
6. The name is absent
7. The Value of Cultural Heritage Sites in Armenia: Evidence From a Travel Cost Method Study
8. IMPROVING THE UNIVERSITY'S PERFORMANCE IN PUBLIC POLICY EDUCATION
9. The name is absent
10. Dementia Care Mapping and Patient-Centred Care in Australian residential homes: An economic evaluation of the CARE Study, CHERE Working Paper 2008/4